David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
CALL
Assured Guaranty
AGO
$3.3B
| $3.04M | ﹤0.01% |
117,900
| – | – |
|
1777
Sarepta Therapeutics
SRPT
$2B
| $3.04M | ﹤0.01% |
31,060
+27,228
| +711% | +$3.11M |
|
1778
Takeda Pharmaceutical
TAK
$58.6B
| $3.04M | ﹤0.01% |
200,080
-340,536
| -63% | -$6.17M |
|
1779
PUT
Bread Financial
BFH
$4.14B
| $3.02M | ﹤0.01% |
112,645
+9,398
| +9% | +$640K |
|
1780
CALL
Capital One
COF
$133B
| $3.02M | ﹤0.01% |
60,000
-16,500
| -22% | -$1.45M |
|
|
CXO
1781
CALL
DELISTED
CONCHO RESOURCES INC.
CXO
| $3.02M | ﹤0.01% |
70,600
-5,000
| -7% | -$348K |
|
1782
Emcor
EME
$32.6B
| $3.02M | ﹤0.01% |
49,281
+43,483
| +750% | +$3.35M |
|
1783
Molson Coors Class B
TAP
$7.83B
| $3.01M | ﹤0.01% |
77,209
-245,090
| -76% | -$12.4M |
|
|
HUD
1784
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $3M | ﹤0.01% |
598,399
+260,694
| +77% | +$2.58M |
|
|
DCH
1785
Dauch Corp
DCH
$1.53B
| $3M | ﹤0.01% |
829,732
+165,582
| +25% | +$1.23M |
|
1786
PUT
Ralph Lauren
RL
$21.6B
| $2.99M | ﹤0.01% |
44,800
-29,100
| -39% | -$3.06M |
|
1787
Energizer
ENR
$1.5B
| $2.99M | ﹤0.01% |
98,945
+82,071
| +486% | +$3.72M |
|
1788
Papa John's
PZZA
$794M
| $2.99M | ﹤0.01% |
56,087
-18,215
| -25% | -$1.1M |
|
1789
OR Royalties Inc
OR
$7.29B
| $2.99M | ﹤0.01% |
401,434
+234,474
| +140% | +$2.08M |
|
|
ONDK
1790
DELISTED
On Deck Capital, Inc.
ONDK
| $2.99M | ﹤0.01% |
1,938,858
-272,755
| -12% | -$889K |
|
1791
Regenxbio
RGNX
$588M
| $2.98M | ﹤0.01% |
92,163
+68,402
| +288% | +$2.85M |
|
1792
Phibro Animal Health
PAHC
$1.43B
| $2.98M | ﹤0.01% |
123,249
+44,621
| +57% | +$1.09M |
|
1793
Illinois Tool Works
ITW
$80.2B
| $2.97M | ﹤0.01% |
+20,880
| New | +$3.55M |
|
|
ZUO
1794
DELISTED
Zuora, Inc.
ZUO
| $2.96M | ﹤0.01% |
368,172
+55,545
| +18% | +$731K |
|
1795
Insperity
NSP
$2B
| $2.96M | ﹤0.01% |
79,381
-139,527
| -64% | -$9.9M |
|
1796
FormFactor
FORM
$8.42B
| $2.96M | ﹤0.01% |
147,158
+136,116
| +1,233% | +$3.25M |
|
1797
CALL
Synaptics
SYNA
$3.71B
| $2.96M | ﹤0.01% |
51,100
+22,800
| +81% | +$1.55M |
|
|
DRNA
1798
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.96M | ﹤0.01% |
160,849
+41,579
| +35% | +$808K |
|
1799
PUT
Coherent
COHR
$56.4B
| $2.95M | ﹤0.01% |
103,600
| – | – |
|
|
BERY
1800
PUT
DELISTED
Berry Global Group, Inc.
BERY
| $2.95M | ﹤0.01% |
95,396
+52,816
| +124% | +$1.94M |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.